# | ||||
---|---|---|---|---|
1 | FAIR-PARK-II Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | 2015 | 8˙263˙202.00 | 5˙998˙994.00 |
The Institution CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE has been involved also in the following Horizon 2020 projects.